Found 6 hits for monomerid = 50075817 Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kcal/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Vasopressin V2 Receptor
(Rattus norvegicus (Rat)) | BDBM50075817
(CHEMBL2371240 | Mpa-Car-lle-Gln-Asn-Cys-Sar-Arg-Gl...)Show SMILES [H][C@]12N(CCc3c1[nH]c1ccccc31)C(=O)CCSSC[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@]([H])(NC2=O)[C@@H](C)CC)C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O |wU:59.62,42.45,1.0,wD:21.54,25.28,33.36,47.51,(5.28,-12.92,;7.12,-12.63,;8.46,-11.86,;8.46,-10.32,;7.12,-9.55,;5.8,-10.32,;5.8,-11.86,;4.32,-12.34,;3.42,-11.09,;1.89,-10.93,;1.27,-9.52,;2.17,-8.27,;3.7,-8.44,;4.32,-9.85,;9.97,-11.53,;9.88,-10,;11.49,-11.7,;12.91,-12.33,;14.05,-13.35,;14.82,-14.69,;15.14,-16.21,;14.98,-17.73,;14.35,-19.14,;13.33,-20.28,;14.28,-21.17,;11.99,-21.06,;12.54,-22.49,;14.06,-22.73,;14.61,-24.17,;15.1,-21.86,;10.49,-21.38,;8.95,-21.21,;8.55,-22.7,;7.54,-20.58,;6.71,-21.87,;7.4,-23.25,;6.57,-24.54,;5.03,-24.46,;7.26,-25.92,;6.4,-19.54,;5.62,-18.22,;4.19,-18.78,;5.31,-16.72,;4.02,-15.37,;5.46,-15.18,;6.1,-13.77,;4.91,-13.32,;3.77,-16.8,;2.93,-15.51,;3.07,-18.16,;1.52,-18.26,;16.47,-18.12,;17.56,-17.04,;16.87,-19.61,;15.77,-20.71,;18.36,-20.01,;19.45,-18.93,;19.05,-17.44,;20.93,-19.33,;22.01,-18.24,;21.62,-16.75,;22.71,-15.66,;22.31,-14.16,;23.4,-13.07,;23.01,-11.6,;24.08,-10.51,;21.51,-11.2,;23.5,-18.64,;23.9,-20.13,;24.6,-17.54,;26.09,-17.94,;27.17,-16.86,;28.67,-17.25,;26.78,-15.37,)| Show InChI InChI=1S/C44H65N15O11S2/c1-4-22(2)35-41(68)54-27(11-12-30(45)60)39(66)55-28(18-31(46)61)40(67)56-29(43(70)58(3)20-33(63)52-26(10-7-15-50-44(48)49)38(65)51-19-32(47)62)21-72-71-17-14-34(64)59-16-13-24-23-8-5-6-9-25(23)53-36(24)37(59)42(69)57-35/h5-6,8-9,22,26-29,35,37,53H,4,7,10-21H2,1-3H3,(H2,45,60)(H2,46,61)(H2,47,62)(H,51,65)(H,52,63)(H,54,68)(H,55,66)(H,56,67)(H,57,69)(H4,48,49,50)/t22-,26-,27-,28-,29+,35-,37-/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet 
| CHEMBL
PC cid
PC sid
UniChem
| PubMed
| n/a | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a |
Albert Szent-Gy£rgyi Medical University
Curated by ChEMBL
| Assay Description
Compound was evaluated for its dissociation constant (Kd) to rat kidney Vasopressin V2 receptor |
Bioorg Med Chem Lett 9: 667-72 (1999)
BindingDB Entry DOI: 10.7270/Q2QC040K |
More data for this
Ligand-Target Pair | |
Vasopressin V1 receptor
(RAT) | BDBM50075817
(CHEMBL2371240 | Mpa-Car-lle-Gln-Asn-Cys-Sar-Arg-Gl...)Show SMILES [H][C@]12N(CCc3c1[nH]c1ccccc31)C(=O)CCSSC[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@]([H])(NC2=O)[C@@H](C)CC)C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O |wU:59.62,42.45,1.0,wD:21.54,25.28,33.36,47.51,(5.28,-12.92,;7.12,-12.63,;8.46,-11.86,;8.46,-10.32,;7.12,-9.55,;5.8,-10.32,;5.8,-11.86,;4.32,-12.34,;3.42,-11.09,;1.89,-10.93,;1.27,-9.52,;2.17,-8.27,;3.7,-8.44,;4.32,-9.85,;9.97,-11.53,;9.88,-10,;11.49,-11.7,;12.91,-12.33,;14.05,-13.35,;14.82,-14.69,;15.14,-16.21,;14.98,-17.73,;14.35,-19.14,;13.33,-20.28,;14.28,-21.17,;11.99,-21.06,;12.54,-22.49,;14.06,-22.73,;14.61,-24.17,;15.1,-21.86,;10.49,-21.38,;8.95,-21.21,;8.55,-22.7,;7.54,-20.58,;6.71,-21.87,;7.4,-23.25,;6.57,-24.54,;5.03,-24.46,;7.26,-25.92,;6.4,-19.54,;5.62,-18.22,;4.19,-18.78,;5.31,-16.72,;4.02,-15.37,;5.46,-15.18,;6.1,-13.77,;4.91,-13.32,;3.77,-16.8,;2.93,-15.51,;3.07,-18.16,;1.52,-18.26,;16.47,-18.12,;17.56,-17.04,;16.87,-19.61,;15.77,-20.71,;18.36,-20.01,;19.45,-18.93,;19.05,-17.44,;20.93,-19.33,;22.01,-18.24,;21.62,-16.75,;22.71,-15.66,;22.31,-14.16,;23.4,-13.07,;23.01,-11.6,;24.08,-10.51,;21.51,-11.2,;23.5,-18.64,;23.9,-20.13,;24.6,-17.54,;26.09,-17.94,;27.17,-16.86,;28.67,-17.25,;26.78,-15.37,)| Show InChI InChI=1S/C44H65N15O11S2/c1-4-22(2)35-41(68)54-27(11-12-30(45)60)39(66)55-28(18-31(46)61)40(67)56-29(43(70)58(3)20-33(63)52-26(10-7-15-50-44(48)49)38(65)51-19-32(47)62)21-72-71-17-14-34(64)59-16-13-24-23-8-5-6-9-25(23)53-36(24)37(59)42(69)57-35/h5-6,8-9,22,26-29,35,37,53H,4,7,10-21H2,1-3H3,(H2,45,60)(H2,46,61)(H2,47,62)(H,51,65)(H,52,63)(H,54,68)(H,55,66)(H,56,67)(H,57,69)(H4,48,49,50)/t22-,26-,27-,28-,29+,35-,37-/m0/s1 | MMDB
UniProtKB/SwissProt
B.MOAD
DrugBank
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
| PubMed
| n/a | n/a | n/a | 18 | n/a | n/a | n/a | n/a | n/a |
Albert Szent-Gy£rgyi Medical University
Curated by ChEMBL
| Assay Description
Compound was evaluated for its dissociation constant (Kd) to rat liver Vasopressin V1 receptor |
Bioorg Med Chem Lett 9: 667-72 (1999)
BindingDB Entry DOI: 10.7270/Q2QC040K |
More data for this
Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50075817
(CHEMBL2371240 | Mpa-Car-lle-Gln-Asn-Cys-Sar-Arg-Gl...)Show SMILES [H][C@]12N(CCc3c1[nH]c1ccccc31)C(=O)CCSSC[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@]([H])(NC2=O)[C@@H](C)CC)C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O |wU:59.62,42.45,1.0,wD:21.54,25.28,33.36,47.51,(5.28,-12.92,;7.12,-12.63,;8.46,-11.86,;8.46,-10.32,;7.12,-9.55,;5.8,-10.32,;5.8,-11.86,;4.32,-12.34,;3.42,-11.09,;1.89,-10.93,;1.27,-9.52,;2.17,-8.27,;3.7,-8.44,;4.32,-9.85,;9.97,-11.53,;9.88,-10,;11.49,-11.7,;12.91,-12.33,;14.05,-13.35,;14.82,-14.69,;15.14,-16.21,;14.98,-17.73,;14.35,-19.14,;13.33,-20.28,;14.28,-21.17,;11.99,-21.06,;12.54,-22.49,;14.06,-22.73,;14.61,-24.17,;15.1,-21.86,;10.49,-21.38,;8.95,-21.21,;8.55,-22.7,;7.54,-20.58,;6.71,-21.87,;7.4,-23.25,;6.57,-24.54,;5.03,-24.46,;7.26,-25.92,;6.4,-19.54,;5.62,-18.22,;4.19,-18.78,;5.31,-16.72,;4.02,-15.37,;5.46,-15.18,;6.1,-13.77,;4.91,-13.32,;3.77,-16.8,;2.93,-15.51,;3.07,-18.16,;1.52,-18.26,;16.47,-18.12,;17.56,-17.04,;16.87,-19.61,;15.77,-20.71,;18.36,-20.01,;19.45,-18.93,;19.05,-17.44,;20.93,-19.33,;22.01,-18.24,;21.62,-16.75,;22.71,-15.66,;22.31,-14.16,;23.4,-13.07,;23.01,-11.6,;24.08,-10.51,;21.51,-11.2,;23.5,-18.64,;23.9,-20.13,;24.6,-17.54,;26.09,-17.94,;27.17,-16.86,;28.67,-17.25,;26.78,-15.37,)| Show InChI InChI=1S/C44H65N15O11S2/c1-4-22(2)35-41(68)54-27(11-12-30(45)60)39(66)55-28(18-31(46)61)40(67)56-29(43(70)58(3)20-33(63)52-26(10-7-15-50-44(48)49)38(65)51-19-32(47)62)21-72-71-17-14-34(64)59-16-13-24-23-8-5-6-9-25(23)53-36(24)37(59)42(69)57-35/h5-6,8-9,22,26-29,35,37,53H,4,7,10-21H2,1-3H3,(H2,45,60)(H2,46,61)(H2,47,62)(H,51,65)(H,52,63)(H,54,68)(H,55,66)(H,56,67)(H,57,69)(H4,48,49,50)/t22-,26-,27-,28-,29+,35-,37-/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
| PubMed
| n/a | n/a | n/a | 8.55E+3 | n/a | n/a | n/a | n/a | n/a |
Albert Szent-Gy£rgyi Medical University
Curated by ChEMBL
| Assay Description
Compound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptor |
Bioorg Med Chem Lett 9: 667-72 (1999)
BindingDB Entry DOI: 10.7270/Q2QC040K |
More data for this
Ligand-Target Pair | |
Vasopressin receptor
(Rattus norvegicus (Rat)) | BDBM50075817
(CHEMBL2371240 | Mpa-Car-lle-Gln-Asn-Cys-Sar-Arg-Gl...)Show SMILES [H][C@]12N(CCc3c1[nH]c1ccccc31)C(=O)CCSSC[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@]([H])(NC2=O)[C@@H](C)CC)C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O |wU:59.62,42.45,1.0,wD:21.54,25.28,33.36,47.51,(5.28,-12.92,;7.12,-12.63,;8.46,-11.86,;8.46,-10.32,;7.12,-9.55,;5.8,-10.32,;5.8,-11.86,;4.32,-12.34,;3.42,-11.09,;1.89,-10.93,;1.27,-9.52,;2.17,-8.27,;3.7,-8.44,;4.32,-9.85,;9.97,-11.53,;9.88,-10,;11.49,-11.7,;12.91,-12.33,;14.05,-13.35,;14.82,-14.69,;15.14,-16.21,;14.98,-17.73,;14.35,-19.14,;13.33,-20.28,;14.28,-21.17,;11.99,-21.06,;12.54,-22.49,;14.06,-22.73,;14.61,-24.17,;15.1,-21.86,;10.49,-21.38,;8.95,-21.21,;8.55,-22.7,;7.54,-20.58,;6.71,-21.87,;7.4,-23.25,;6.57,-24.54,;5.03,-24.46,;7.26,-25.92,;6.4,-19.54,;5.62,-18.22,;4.19,-18.78,;5.31,-16.72,;4.02,-15.37,;5.46,-15.18,;6.1,-13.77,;4.91,-13.32,;3.77,-16.8,;2.93,-15.51,;3.07,-18.16,;1.52,-18.26,;16.47,-18.12,;17.56,-17.04,;16.87,-19.61,;15.77,-20.71,;18.36,-20.01,;19.45,-18.93,;19.05,-17.44,;20.93,-19.33,;22.01,-18.24,;21.62,-16.75,;22.71,-15.66,;22.31,-14.16,;23.4,-13.07,;23.01,-11.6,;24.08,-10.51,;21.51,-11.2,;23.5,-18.64,;23.9,-20.13,;24.6,-17.54,;26.09,-17.94,;27.17,-16.86,;28.67,-17.25,;26.78,-15.37,)| Show InChI InChI=1S/C44H65N15O11S2/c1-4-22(2)35-41(68)54-27(11-12-30(45)60)39(66)55-28(18-31(46)61)40(67)56-29(43(70)58(3)20-33(63)52-26(10-7-15-50-44(48)49)38(65)51-19-32(47)62)21-72-71-17-14-34(64)59-16-13-24-23-8-5-6-9-25(23)53-36(24)37(59)42(69)57-35/h5-6,8-9,22,26-29,35,37,53H,4,7,10-21H2,1-3H3,(H2,45,60)(H2,46,61)(H2,47,62)(H,51,65)(H,52,63)(H,54,68)(H,55,66)(H,56,67)(H,57,69)(H4,48,49,50)/t22-,26-,27-,28-,29+,35-,37-/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
| PubMed
| n/a | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a |
Albert Szent-Gy£rgyi Medical University
Curated by ChEMBL
| Assay Description
Compound was evaluated for its dissociation constant (Kd) to rat kidney Vasopressin V2 receptor |
Bioorg Med Chem Lett 9: 667-72 (1999)
BindingDB Entry DOI: 10.7270/Q2QC040K |
More data for this
Ligand-Target Pair | |
Vasopressin V1 receptor
(RAT) | BDBM50075817
(CHEMBL2371240 | Mpa-Car-lle-Gln-Asn-Cys-Sar-Arg-Gl...)Show SMILES [H][C@]12N(CCc3c1[nH]c1ccccc31)C(=O)CCSSC[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@]([H])(NC2=O)[C@@H](C)CC)C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O |wU:59.62,42.45,1.0,wD:21.54,25.28,33.36,47.51,(5.28,-12.92,;7.12,-12.63,;8.46,-11.86,;8.46,-10.32,;7.12,-9.55,;5.8,-10.32,;5.8,-11.86,;4.32,-12.34,;3.42,-11.09,;1.89,-10.93,;1.27,-9.52,;2.17,-8.27,;3.7,-8.44,;4.32,-9.85,;9.97,-11.53,;9.88,-10,;11.49,-11.7,;12.91,-12.33,;14.05,-13.35,;14.82,-14.69,;15.14,-16.21,;14.98,-17.73,;14.35,-19.14,;13.33,-20.28,;14.28,-21.17,;11.99,-21.06,;12.54,-22.49,;14.06,-22.73,;14.61,-24.17,;15.1,-21.86,;10.49,-21.38,;8.95,-21.21,;8.55,-22.7,;7.54,-20.58,;6.71,-21.87,;7.4,-23.25,;6.57,-24.54,;5.03,-24.46,;7.26,-25.92,;6.4,-19.54,;5.62,-18.22,;4.19,-18.78,;5.31,-16.72,;4.02,-15.37,;5.46,-15.18,;6.1,-13.77,;4.91,-13.32,;3.77,-16.8,;2.93,-15.51,;3.07,-18.16,;1.52,-18.26,;16.47,-18.12,;17.56,-17.04,;16.87,-19.61,;15.77,-20.71,;18.36,-20.01,;19.45,-18.93,;19.05,-17.44,;20.93,-19.33,;22.01,-18.24,;21.62,-16.75,;22.71,-15.66,;22.31,-14.16,;23.4,-13.07,;23.01,-11.6,;24.08,-10.51,;21.51,-11.2,;23.5,-18.64,;23.9,-20.13,;24.6,-17.54,;26.09,-17.94,;27.17,-16.86,;28.67,-17.25,;26.78,-15.37,)| Show InChI InChI=1S/C44H65N15O11S2/c1-4-22(2)35-41(68)54-27(11-12-30(45)60)39(66)55-28(18-31(46)61)40(67)56-29(43(70)58(3)20-33(63)52-26(10-7-15-50-44(48)49)38(65)51-19-32(47)62)21-72-71-17-14-34(64)59-16-13-24-23-8-5-6-9-25(23)53-36(24)37(59)42(69)57-35/h5-6,8-9,22,26-29,35,37,53H,4,7,10-21H2,1-3H3,(H2,45,60)(H2,46,61)(H2,47,62)(H,51,65)(H,52,63)(H,54,68)(H,55,66)(H,56,67)(H,57,69)(H4,48,49,50)/t22-,26-,27-,28-,29+,35-,37-/m0/s1 | MMDB
UniProtKB/SwissProt
B.MOAD
DrugBank
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
| PubMed
| n/a | n/a | n/a | 64 | n/a | n/a | n/a | n/a | n/a |
Albert Szent-Gy£rgyi Medical University
Curated by ChEMBL
| Assay Description
Compound was evaluated for its dissociation constant (Kd) to rat liver Vasopressin V1 receptor |
Bioorg Med Chem Lett 9: 667-72 (1999)
BindingDB Entry DOI: 10.7270/Q2QC040K |
More data for this
Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50075817
(CHEMBL2371240 | Mpa-Car-lle-Gln-Asn-Cys-Sar-Arg-Gl...)Show SMILES [H][C@]12N(CCc3c1[nH]c1ccccc31)C(=O)CCSSC[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@]([H])(NC2=O)[C@@H](C)CC)C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O |wU:59.62,42.45,1.0,wD:21.54,25.28,33.36,47.51,(5.28,-12.92,;7.12,-12.63,;8.46,-11.86,;8.46,-10.32,;7.12,-9.55,;5.8,-10.32,;5.8,-11.86,;4.32,-12.34,;3.42,-11.09,;1.89,-10.93,;1.27,-9.52,;2.17,-8.27,;3.7,-8.44,;4.32,-9.85,;9.97,-11.53,;9.88,-10,;11.49,-11.7,;12.91,-12.33,;14.05,-13.35,;14.82,-14.69,;15.14,-16.21,;14.98,-17.73,;14.35,-19.14,;13.33,-20.28,;14.28,-21.17,;11.99,-21.06,;12.54,-22.49,;14.06,-22.73,;14.61,-24.17,;15.1,-21.86,;10.49,-21.38,;8.95,-21.21,;8.55,-22.7,;7.54,-20.58,;6.71,-21.87,;7.4,-23.25,;6.57,-24.54,;5.03,-24.46,;7.26,-25.92,;6.4,-19.54,;5.62,-18.22,;4.19,-18.78,;5.31,-16.72,;4.02,-15.37,;5.46,-15.18,;6.1,-13.77,;4.91,-13.32,;3.77,-16.8,;2.93,-15.51,;3.07,-18.16,;1.52,-18.26,;16.47,-18.12,;17.56,-17.04,;16.87,-19.61,;15.77,-20.71,;18.36,-20.01,;19.45,-18.93,;19.05,-17.44,;20.93,-19.33,;22.01,-18.24,;21.62,-16.75,;22.71,-15.66,;22.31,-14.16,;23.4,-13.07,;23.01,-11.6,;24.08,-10.51,;21.51,-11.2,;23.5,-18.64,;23.9,-20.13,;24.6,-17.54,;26.09,-17.94,;27.17,-16.86,;28.67,-17.25,;26.78,-15.37,)| Show InChI InChI=1S/C44H65N15O11S2/c1-4-22(2)35-41(68)54-27(11-12-30(45)60)39(66)55-28(18-31(46)61)40(67)56-29(43(70)58(3)20-33(63)52-26(10-7-15-50-44(48)49)38(65)51-19-32(47)62)21-72-71-17-14-34(64)59-16-13-24-23-8-5-6-9-25(23)53-36(24)37(59)42(69)57-35/h5-6,8-9,22,26-29,35,37,53H,4,7,10-21H2,1-3H3,(H2,45,60)(H2,46,61)(H2,47,62)(H,51,65)(H,52,63)(H,54,68)(H,55,66)(H,56,67)(H,57,69)(H4,48,49,50)/t22-,26-,27-,28-,29+,35-,37-/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
| PubMed
| n/a | n/a | n/a | 5.75E+4 | n/a | n/a | n/a | n/a | n/a |
Albert Szent-Gy£rgyi Medical University
Curated by ChEMBL
| Assay Description
Compound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptor |
Bioorg Med Chem Lett 9: 667-72 (1999)
BindingDB Entry DOI: 10.7270/Q2QC040K |
More data for this
Ligand-Target Pair | |
Search and Browse
